Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations
Clinical trial NCT06029816 · UNKNOWN
Trial details
- NCT number
- NCT06029816
- Sponsor
- Convalife (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2024-12-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.